Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 31% ± 9% | |
intestine | 10 studies | 27% ± 12% | |
lung | 9 studies | 28% ± 9% | |
liver | 6 studies | 28% ± 17% | |
kidney | 5 studies | 27% ± 8% | |
bone marrow | 5 studies | 27% ± 12% | |
lymph node | 5 studies | 31% ± 6% | |
uterus | 4 studies | 29% ± 12% | |
breast | 4 studies | 30% ± 13% | |
pancreas | 3 studies | 35% ± 8% | |
prostate | 3 studies | 33% ± 12% | |
brain | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 10530.17 | 180 / 180 | 100% | 343.62 | 430 / 430 |
skin | 100% | 8909.03 | 1809 / 1809 | 100% | 248.01 | 472 / 472 |
uterus | 100% | 7240.24 | 170 / 170 | 100% | 396.82 | 459 / 459 |
esophagus | 100% | 5099.21 | 1444 / 1445 | 100% | 184.71 | 183 / 183 |
thymus | 100% | 4399.19 | 652 / 653 | 100% | 218.11 | 604 / 605 |
prostate | 100% | 5159.77 | 245 / 245 | 100% | 217.08 | 500 / 502 |
pancreas | 100% | 3978.12 | 328 / 328 | 99% | 228.70 | 177 / 178 |
stomach | 100% | 3612.77 | 359 / 359 | 99% | 279.71 | 284 / 286 |
intestine | 100% | 4560.88 | 966 / 966 | 99% | 341.34 | 523 / 527 |
breast | 100% | 6589.11 | 459 / 459 | 99% | 232.43 | 1107 / 1118 |
bladder | 100% | 5473.00 | 21 / 21 | 99% | 323.15 | 499 / 504 |
lung | 99% | 3842.09 | 575 / 578 | 99% | 250.05 | 1142 / 1155 |
brain | 99% | 2041.93 | 2603 / 2642 | 98% | 132.40 | 692 / 705 |
kidney | 100% | 3225.84 | 89 / 89 | 95% | 136.53 | 858 / 901 |
adrenal gland | 100% | 3652.93 | 258 / 258 | 94% | 117.91 | 217 / 230 |
liver | 98% | 1867.42 | 222 / 226 | 96% | 159.50 | 390 / 406 |
adipose | 100% | 5347.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 316.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 476.32 | 29 / 29 |
spleen | 100% | 5676.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 359.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 202.87 | 1 / 1 |
blood vessel | 100% | 3938.48 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 3085.54 | 796 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 5514.48 | 878 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 2020.87 | 813 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048254 | Biological process | snoRNA localization |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0031167 | Biological process | rRNA methylation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042274 | Biological process | ribosomal small subunit biogenesis |
GO_0006364 | Biological process | rRNA processing |
GO_0000494 | Biological process | box C/D sno(s)RNA 3'-end processing |
GO_0005730 | Cellular component | nucleolus |
GO_0001652 | Cellular component | granular component |
GO_0016020 | Cellular component | membrane |
GO_0032040 | Cellular component | small-subunit processome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0015030 | Cellular component | Cajal body |
GO_0031428 | Cellular component | box C/D methylation guide snoRNP complex |
GO_0005634 | Cellular component | nucleus |
GO_0001094 | Molecular function | TFIID-class transcription factor complex binding |
GO_0180021 | Molecular function | U6 snRNA 2'-O-ribose methyltransferase activity |
GO_1990259 | Molecular function | histone H2AQ104 methyltransferase activity |
GO_0008649 | Molecular function | rRNA methyltransferase activity |
GO_0051117 | Molecular function | ATPase binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FBL |
Protein name | rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin) Fibrillarin FBL protein |
Synonyms | FLRN FIB1 |
Description | FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that has the ability to methylate both RNAs and proteins . Involved in pre-rRNA processing by catalyzing the site-specific 2'-hydroxyl methylation of ribose moieties in pre-ribosomal RNA . Site specificity is provided by a guide RNA that base pairs with the substrate (By similarity). Methylation occurs at a characteristic distance from the sequence involved in base pairing with the guide RNA (By similarity). Probably catalyzes 2'-O-methylation of U6 snRNAs in box C/D RNP complexes . U6 snRNA 2'-O-methylation is required for mRNA splicing fidelity . Also acts as a protein methyltransferase by mediating methylation of 'Gln-105' of histone H2A (H2AQ104me), a modification that impairs binding of the FACT complex and is specifically present at 35S ribosomal DNA locus . Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome . . |
Accessions | M0QXL5 ENST00000598417.5 ENST00000628079 M0R2Q4 ENST00000597634.5 ENST00000597224.5 ENST00000630954 ENST00000601274.5 M0R2B0 ENST00000625673 ENST00000629964 M0R299 ENST00000630592 ENST00000625241.3 M0R2U2 ENST00000594443.5 M0R0P1 ENST00000595545.5 ENST00000599134.1 ENST00000221801.8 ENST00000594309.5 Q96BS4 ENST00000629606 P22087 M0R1H0 M0QXC9 ENST00000629982 ENST00000627797 |